Skip to content

Biohaven BHVN Retained Earnings

Retained Earnings at other companies

Eli Lilly logo
Eli LillyLLY
$29.51B+95.5%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-$1.35B-39.7%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-$255.09M-72.6%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-$1.32B-50.3%
uniQure logo
uniQureQURE
-$1.38B-17.8%
Roivant Sciences logo
Roivant SciencesROIV
-$501.81M-532%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's retained earnings?
Biohaven (BHVN) reported retained earnings of -$2.22B in Q1 2026.
How has Biohaven's retained earnings changed year-over-year?
Biohaven's retained earnings decreased by 41.3% year-over-year, from -$1.57B to -$2.22B.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.